Also on this list
Bayan Health
$129 flat at every dose, on a protocol its Terms say you cannot leave.
Another provider on our tesamorelin provider ranking.
Read the Bayan Health review →Provider review
Oak lists tirzepatide at From $185/mo (12-mo plan), semaglutide at From $119/mo (12-mo plan) and NAD+ at $175/mo. It publishes no price for tesamorelin. Prices checked October 2026.
Its headline price needs a 12-month plan — and no pharmacy is named anywhere.
Oak prices compounded semaglutide from $119 a month and tirzepatide from $185, both on a 12-month plan, and says "Membership Fees: None." Shorter plans are priced only at checkout, and no page names the pharmacy that fills your prescription.
Transparency scorecard
1 of 4 disclosed openly
What Oak discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
States no federal regulatory category (503A/503B) for its pharmacy on its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
Also on this list
Bayan Health
$129 flat at every dose, on a protocol its Terms say you cannot leave.
Another provider on our tesamorelin provider ranking.
Read the Bayan Health review →| Compound | Advertised | What you pay monthly | Pharmacy | Checked |
|---|---|---|---|---|
| Tirzepatide | From $185/mo (12-mo plan) | From $185/mo (12-mo plan) | Not disclosed | October 2026 |
| Semaglutide | From $119/mo (12-mo plan) | From $119/mo (12-mo plan) | Not disclosed | October 2026 |
| NAD+ | $175/mo | $175/mo | Not disclosed | October 2026 |
| Tesamorelin | Not published | Not published | Not disclosed | October 2026 |
What this price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Not confirmed
Lab work
Not disclosed
Coaching
Not confirmed
The catch — $185 and $119 are 12-month-plan rates. The price for anything shorter appears only at checkout, after an identity check.
See plans at OakPrices read from Oak's own site
What they advertise
Oak's own pages read "$185 Per month, 12-month plan" for tirzepatide and "$119 Per month, 12-month plan" for semaglutide. NAD+ is $175 a month for a one-month supply, "regularly $199".
What you actually pay
Not published. Oak says "Shorter plans are available, and you see your exact price before you pay", but its GLP-1 sign-up asks for the last four digits of your Social Security number (or a photo ID) before it shows any plan price.
Money you will meet later
Oak (Oak Longevity) sells compounded semaglutide from $119/mo and compounded tirzepatide from $185/mo, both on a 12-month plan, plus branded GLP-1 injections and oral Wegovy priced at checkout. Its longevity line now prices NAD+ at $175 a month (struck from $199), with sermorelin and tesamorelin priced only after an assessment. Both GLP-1 pages say plainly that compounded medications are not FDA approved, and both prices are FSA/HSA eligible. Its Terms put coverage at "45 states", a real number rather than "nationwide", though the list those Terms point to isn't published. What holds it back: no pharmacy is named anywhere, no 503A or 503B category is stated, and once a provider approves you and the order reaches the pharmacy, it cannot be canceled or refunded.
Oak appears on our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking, our tesamorelin provider ranking and our combined weight loss injections ranking.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Oak states no 503A/503B category for the pharmacy that fills your prescription.
Oak never names a pharmacy — not on the product pages and not in the Terms of Use, which refer only to an "Oak Pharmacy Network" and "licensed US pharmacies." Neither "503A" nor "503B" appears anywhere on the site.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Oak's Terms of Use put it at "45 states" — a real number rather than a vague "nationwide." The list those Terms point to, in an FAQ section, isn't on the live site.
The part they would rather you skipped
Oak never names the pharmacy that fills your prescription, and never says whether it is a 503A or a 503B. Its Terms mention only an "Oak Pharmacy Network". Its refund terms are also strict: once a provider approves your treatment and the order reaches the pharmacy, it "can no longer be cancelled and is non-refundable", even if you cancel your subscription right after approval.
Other providers on our tesamorelin provider ranking — the closest match to what Oak sells.



A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Oak's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Oak's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Oak's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Oak
4 compounds, From $119/mo (12-mo plan)